Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma

Journal of Trauma - Injury, Infection and Critical Care

Volumn 57, Issue 5, 2004, Pages 1006-1012

  Pelinka, Linda E ^a   Kroepfl, Alfred ^b   Schmidhammer, R ^a   Krenn, Manfred ^c   Buchinger, Walter ^d   Redl, Heinz ^a   Raabe, Andreas ^e  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b Trauma Hospital   (Austria)

^c Mistelbach General Hospital   (Austria)

^d Waldviertel Clinic   (Austria)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

Brain specificity; Intracranial pressure cerebral perfusion pressure; Multiple trauma; Outcome; Secondary brain damage

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ARTICLE; BRAIN INJURY; BRAIN PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOCUMENTATION; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE TRAUMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL;

ADULT; AUSTRIA; BIOLOGICAL MARKERS; BRAIN INJURIES; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTRACRANIAL PRESSURE; MULTIPLE TRAUMA; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TRAUMA CENTERS; TREATMENT OUTCOME;

EID: 9644300826     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000108998.48026.C3     Document Type: Article

References (32)

1. Maier B, Schwerdtfeger K, Mautes A, et al. Differential release of interleukins 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock. 2001;15:421-426.
2. Jacobs A, Put E, Ingels M, Put T, Bossuyt A. One-year follow-up of technetium-99m-HMPAO SPECT in mild head injury. J Nucl Med. 1996;37:1605-1609.
3. Kant R, Smith-Seemiller L, Isaac G, Duffy J. Tc-HMPAO SPECT in persistent postconcussion syndrome after mild head injury: comparison with MRI/CT. Brain Inj. 1997;11:115-124.
4. Mitchener A, Wyper DJ, Patterson J, et al. SPECT, CT, and MRI in head injury: acute abnormalities followed up at six months. J Neurol Neurosurg Psychiatry. 1997;62:633-636.
5. Chesnut RM. Avoidance of hypotension: condition sine qua non of successful severe head injury management. J Trauma. 1997;42:S4-S9.
6. Ingebrigtsen T, Romner B. Biochemical serum markers of traumatic brain injury. J Trauma. 2002;52:798-808.
7. Bakay RA, Ward AA Jr. Enzymatic changes in serum and cerebrospinal fluid in neurological injury. J Neurosurg. 1983;58:27-37.
8. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;48:1255-1258.
9. Pelinka LE, Toegel E, Mauritz W, Redl H. Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock. 2003;19:195-200.
10. Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma. 2000;17:113-122.
11. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery. 1999;45:477-483.
12. Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18:911-918.
13. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001;18:491-498.
14. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull. 1995;37:417-429.
15. Isobe T, Takahashi K, Okuyama T. S100a0 (alpha alpha) protein is present in neurons of the central and peripheral nervous system. J Neurochem. 1984;43:1494-1496.
16. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28:1956-1960.
17. Regner A, Alves LB, Chemale I, et al. Neurochemical characterization of traumatic brain injury in humans. J Neurotrauma. 2001;18:783-792.
18. van Geel WJ, de Reus HP, Nijzing H, Verbeek MM, Vos PE, Lamers KJ. Measurement of glial fibrillary acidic protein in blood: an analytical method. Clin Chim Acta. 2002;326:151-154.
19. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstrom H. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem. 1999;45:138-141.
20. Marshall LF, Marhsall SB, Klauber MR, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9(suppl 1):S287-S292.
21. Webster MJ, Knable MB, Johnston-Wilson N, Nagata K, Inagaki M, Yolken RH. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun. 2001;15:388-400.
22. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 2000;31:2670-2677.
23. Pelinka L, Bahrami S, Szalay L, Umar F, Redl H. Hemorrhagic shock induces an S 100 B increase associated with shock severity. Shock 2003, in press.
24. Ashikaga R, Araki Y, Ishida O. MRI of head injury using FLAIR. Neuroradiology. 1997;39:239-242.
25. Adelson PD, Jenkins LW, Hamilton RL, Robichaud P, Tran MP, Kochanek PM. Histopathologic response of the immature rat to diffuse traumatic brain injury. J Neurotrauma. 2001;18:967-976.
26. Petersson KH, Pinar H, Stopa EG, et al. White matter injury after cerebral ischemia in ovine fetuses. Pediatr Res. 2002;51:768-776.
27. Noppe M, Crols R, Andries D, Lowenthal A. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100, and myelin basic protein as indices of nonspecific or specific central nervous tissue pathology. Clin Chim Acta. 1986;155:143-150.
28. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 1991;22:1254-1258.
29. Rosengren LE, Wikkelso C, Hagberg L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci. Methods. 1994;51:197-204.
30. Albrechtsen M, Massaro A, Bock E. Enzyme-linked immunosorbent assay for the human glial fibrillary acidic protein using a mouse monoclonal antibody. J Neurochem. 1985;44:560-566.
31. Kraus JF. Epidemilogy of brain injury. In: Narayan RK, et al., eds. Neurotrauma. New York: McGraw Hill; 1996:13-30.
32. Valadka AB. Injury to the cranium. In: Fedliciano DV, et al., eds. Trauma. Norwalk, CT: Appleton & Lange; 1996:267-278.